Clinical Trials on CCO in New Zealand
Total 15 results
-
Rigshospitalet, DenmarkAarhus University Hospital; Hvidovre University Hospital; Bispebjerg Hospital; Vejle... and other collaboratorsCompletedArthroplasty Complications | Co-morbidity | Postoperative MorbidityDenmark
-
All India Institute of Medical Sciences, New DelhiNational AIDS Control OrganisationCompletedHIV/TB Co-infectionIndia
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)CompletedHepatitis C | HIV | Co-InfectionUnited States
-
Institute of Liver and Biliary Sciences, IndiaCompletedEffectiveness of Video Based Education Versus Music Therapy on Anxiety, Experience, and Co-operation Among Patients Undergoing Magnetic Resonance ImagingIndia
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV-1 and Hepatitis C Co-InfectionUnited States
-
Icahn School of Medicine at Mount SinaiGilead SciencesCompletedHepatitis C InfectionUnited States
-
Gilead SciencesCompletedHIV | Hepatitis C VirusUnited States, New Zealand, Canada, Puerto Rico
-
Andrea BranchNational Institute on Drug Abuse (NIDA)Completed
-
NYU Langone HealthCompletedChronic Cough (CC) | Gastroesophageal Reflux (GER)United States
-
Impulse DynamicsRecruitingHeart Failure | Arrhythmias, Cardiac | Ventricular Fibrillation | Ventricular Tachycardia | Implantable Defibrillator User | Heart Failure With Reduced Ejection Fraction | Ischemic Cardiomyopathy | Sudden Cardiac Arrest | Non-ischemic Cardiomyopathy | CCM TherapyUnited States
-
Gilead SciencesCompletedHIV-1/HBV Co-InfectionSpain, Taiwan, Korea, Republic of, Thailand, Hong Kong, Japan, France, Turkey, Puerto Rico, Malaysia, United States, China, Dominican Republic, Greece
-
Ministry of Science and Technology, IndiaIndian Council of Medical ResearchUnknownImpact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection (HIV-TB)HIV Infections | Tuberculosis | Latent Tuberculosis InfectionIndia
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19United States, United Kingdom, Belgium, Spain, France, Germany, Philippines, Brazil, Colombia, South Africa
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the ProtocolUnited States, Mexico, South Africa, Brazil, Chile, Colombia, Peru, Argentina
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingGlioma | Oligoastrocytoma | Anaplastic Astrocytoma | Oligodendroglioma | Diffuse Astrocytoma | WHO Grade III Glioma | IDH2 Gene Mutation | IDH1 Gene Mutation | 1p/19q Co-deletionUnited States